Summary & Overview

HCPCS Level II P9053: Apheresis Platelet Unit, Leukocyte-Reduced, CMV-Negative, Irradiated

HCPCS Level II code P9053 denotes apheresis-derived platelet units that are leukocyte reduced, cytomegalovirus (CMV) negative, and irradiated. These specialized platelet units are used when patients require enhanced transfusion safety, such as immunocompromised recipients, neonates, or transplant candidates. Nationally, P9053 matters because it identifies higher-acuity blood products with distinct processing steps that affect clinical use, inventory management, and reimbursement pathways.

Major payers in national coverage discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what P9053 represents clinically and operationally, plus guidance on what to expect in payer coverage patterns. The publication outlines typical service settings (hospital transfusion services and outpatient infusion/transfusion centers), common clinical indications for CMV-negative and irradiated platelets, and the billing context for units processed by pheresis and leukocyte reduction.

The analysis includes benchmarks for unit-level coding use, notes on policy updates affecting blood product billing, and clinical context relevant to coding accuracy and claims submission. Data not available in the input is indicated where applicable; the focus is on the code definition, payer landscape, and practical implications for billing and clinical documentation.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareP9053HCPCS Level IIplateletsapheresistransfusionleukocyte reducedCMV-negativeirradiatedblood bank

Billing Code Overview

HCPCS Level II code P9053 describes platelets, pheresis, leukocytes reduced, CMV-negative, irradiated, each unit. This code represents a specialized blood product prepared for transfusion that has undergone pheresis collection, leukocyte reduction, cytomegalovirus (CMV) seronegative selection, and irradiation to reduce graft-versus-host disease risk. The service type is transfusion/blood product provision. The typical site of service is hospital inpatient or outpatient transfusion center or blood bank setting.

Clinical & Coding Specifications

Clinical Context

A typical patient is a hospitalized adult with thrombocytopenia requiring transfusion support, such as a patient with acute leukemia undergoing chemotherapy, a patient with aplastic anemia, or a surgical patient with active bleeding and platelet count <20,000–50,000/µL depending on clinical circumstances. The blood bank issues P9053 units when platelets must be collected by pheresis, leukocyte reduced to decrease febrile reactions and alloimmunization, cytomegalovirus (CMV)-negative for CMV-seronegative or immunocompromised recipients, and irradiated to prevent transfusion-associated graft-versus-host disease for severely immunosuppressed patients.

Typical clinical workflow:

The treating physician documents indication (for example, severe thrombocytopenia due to chemotherapy) and orders platelet transfusion with required product attributes (pheresis, leukocyte reduced, CMV-negative, irradiated).
The transfusion service reviews the order, confirms patient blood type and CMV status, selects an appropriate P9053 unit, performs required compatibility testing and labeling, and records irradiation in the transfusion record.
Consent for transfusion is obtained per hospital policy; pretransfusion vital signs and baseline documentation are completed.
Nursing administers the platelet unit at the approved rate, monitors for transfusion reactions, and documents post-transfusion vital signs and patient response.
Billing uses HCPCS code P9053 for each unit transfused, with appropriate modifier(s) appended when required by payer rules (for example, modifier 62 for co-surgeon is not applicable to this supply code but payer-specific modifiers listed may be used).

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier/Not otherwise specified	Use when no specific modifier applies and payer accepts an unmodified supply code.
`22`	Increased procedural services	Rare for supply code; used only if payer allows reporting increased service for related physician work when applicable.
`23`	Unusual anesthesia	Not typically used with blood product supply codes; included by payer list but generally not applicable.
`52`	Reduced services	Use when a planned service is partially reduced; rarely applicable to a full unit transfusion.
`53`	Discontinued procedure	Use if transfusion was started but discontinued for patient safety prior to completion if payer allows modifier for supplies.
`55`	Postoperative management only	Not routinely applicable to blood product billing.
`56`	Preoperative management only	Not routinely applicable to blood product billing.
`62`	Two surgeons	Not applicable to transfusion product billing; included in source modifier list but generally unused for `P9053`.
`80`	Assistant surgeon	Not applicable to blood product billing.
`82`	Assistant surgeon (when qualified resident not available)	Not applicable to blood product billing.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services	Use when an APP provides a billable service associated with the transfusion encounter and payer requires linkage.
`NU`	New equipment	Use if payer requires reporting of a new durable medical equipment item; not typically used for blood products.
`QK`	Medical direction of two, three, or four concurrent anesthesia procedures	Not applicable to blood product billing.
`QX`	Service performed by certified nurse anesthetist; CRNA	Not applicable to blood product supply code.

Taxonomy Code	Specialty	Notes
207RH0000X	Hematology & Oncology	Hematologists/oncologists commonly order therapeutic platelet transfusions for chemotherapy-induced thrombocytopenia.
2080P0005X	Transfusion Medicine	Transfusion medicine physicians or blood bank directors oversee product selection and compatibility.
207L00000X	Internal Medicine	Hospitalists and intensivists frequently order platelet transfusions for inpatients.
363LF0006X	Critical Care Medicine	Intensivists manage bleeding and transfusion in critically ill patients.
2083P0205X	Pathology	Pathologists with blood bank duties manage component processing and release.

ICD-10 Code	Description	Clinical Relevance
`D69.6`	Thrombocytopenia, unspecified	Common indication for platelet transfusion when counts are critically low or bleeding occurs.
`D61.9`	Aplastic anemia, unspecified	Patients with marrow failure often require platelet support with products like `P9053`.
`C92.0`	Acute myeloblastic leukemia [AML]	Chemotherapy-induced marrow suppression in leukemia frequently necessitates platelet transfusion.
`C91.0`	Acute lymphoblastic leukemia [ALL]	ALL patients undergoing cytotoxic therapy commonly need platelet transfusions.
`I85.01`	Esophageal varices with bleeding	Active hemorrhage with coagulopathy or thrombocytopenia may prompt platelet transfusion.
`D68.9`	Coagulation defect, unspecified	Coagulopathies with platelet dysfunction or low counts can be an indication for transfusion.
`Z99.1`	Dependence on respirator [ventilator]	Critically ill, ventilated patients may require transfusion support during critical care.
`T80.6`	Transfusion reaction	Listed for documentation when a patient experiences a transfusion reaction during or after administration of `P9053`.

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Performed for pretransfusion testing (type and screen, crossmatch) prior to issuing `P9053`.
`86850`	Blood typing and Rh group; ABO and Rh(D)	Required pretransfusion testing to ensure compatibility for platelet transfusion.
`86860`	Antibody screen (indirect antiglobulin test)	Performed to detect clinically significant alloantibodies before transfusion when indicated.
`86885`	Crossmatch, serologic; major and minor	Used when crossmatching is required for platelet transfusion in certain clinical situations.
`36430`	Transfusion, infusion of blood and blood components	Used by providers to report administration of blood products when CPT reporting is required in the clinical setting.
`99070`	Supplies and materials, noncovered, used in the provision of medical care	Occasionally used to report special noncovered supplies related to transfusion when payer rules permit.

OpenPayer